The Maharashtra Food and Drug Administration (FDA) has issued notices to prominent Bollywood actors Shah Rukh Khan, Ajay Devgn, and Tiger Shroff concerning their involvement in advertisements for chewing elaichi products that contain supari (areca nut). The regulatory body acted under the Food Safety and Standards (Advertisements and Claims) Regulations, 2018, questioning the promotion of such items by public figures given potential health risks associated with areca nut consumption. The notices require the actors to respond within seven days, clarifying their association with the advertisements.

The FDA's action stems from concerns over advertisements that present products like 'Vimal Elaichi' and 'Shikhar Pan Masala' as mere mouth fresheners or elaichi, despite containing supari. Areca nut is classified by the World Health Organization's International Agency for Research on Cancer (IARC) as a Group 1 carcinogen, meaning it is definitively linked to cancer in humans, particularly oral cancers and oral submucous fibrosis. The FDA emphasized that celebrity endorsements carry significant weight, especially among younger audiences, and should not be used to promote products detrimental to public health. Mr. Gauri Shankar Rathi, an FDA official, confirmed the issuance of these notices, highlighting the agency's commitment to ensuring truthful advertising.

This development underscores the escalating scrutiny by regulatory bodies in India over misleading advertising and the ethical responsibilities of celebrity endorsers. The notices serve as a reminder that while products may be legally available, their promotion, especially by influential personalities, comes under public health purview when ingredients like supari are involved. The FDA's move reflects a broader effort to protect consumers from potentially harmful substances often disguised or downplayed in marketing campaigns. Past instances have seen public backlash and regulatory interventions against actors promoting tobacco-related or similar products.

Supporting details regarding the notices and their context include:

  • Legal Basis: Notices issued under the Food Safety and Standards (Advertisements and Claims) Regulations, 2018.
  • Key Ingredient: The FDA's concern centers on 'supari' (areca nut), which has been identified as a Group 1 carcinogen by the IARC.
  • Targeted Advertisements: The notices specifically address advertisements for products such as 'Vimal Elaichi' and 'Shikhar Pan Masala'.
  • Actor Response Period: Shah Rukh Khan, Ajay Devgn, and Tiger Shroff have been given seven days to provide their clarifications to the FDA.
  • Regulatory Aim: The primary objective is to prevent the misleading promotion of products that carry health risks, particularly when endorsed by influential public figures.

The actors' responses within the stipulated seven-day period will determine the next steps for the Maharashtra FDA. Depending on the clarifications provided, the agency could initiate further investigations, issue directives for advertising modifications, or pursue legal avenues to enforce compliance with food safety and advertising standards. This situation is expected to reignite discussions surrounding celebrity endorsement ethics and the responsibilities of public figures in promoting consumer goods in India, potentially influencing future advertising contracts and regulatory oversight in the entertainment and food industries.